. 2022 May 22;29(7):103313. doi: 10.1016/j.sjbs.2022.103313

Table 2.

Area under curve (AUC) for OGTT before and after 8 weeks of melatonin administration.

Time	Group I	Group II	Group III	Group IV
Week 0	18495 ± 2530	17040 ± 1981	32550 ± 3547^a	31440 ± 1245^a
Week 8	18735 ± 6578	17010 ± 2491	48825 ± 4235^a	21045 ± 1478^b

In each raw, results were expressed as mean ± SD, ^arepresents significance compared with the corresponding healthy control group I and brepresents significance compared with the corresponding diabetic group III (P < 0.05). Group I: healthy control rats, group II: melatonin administrated control rats, group III: non-treated STZ diabetic rats and group IV: melatonin treated STZ diabetic rats.